Atlas Trials

Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT02590276 · COMPLETED

Trial details

NCT number
NCT02590276
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Frontotemporal Lobar DegenerationAmyotrophic Lateral Sclerosis
Start date
2015-10-08
Primary completion
2020-10-27
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.